Search research articles
Contact Us
Filters
Showing results (551-560 of 566) with videos related to
Page
of 57
Sort By:
The Lancet. Oncology
|
August 12, 2016
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar, Bruno Paiva, Kenneth C Anderson, et al.
Bone Marrow Transplantation
|
July 11, 2018
Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement
Wilson I Gonsalves, Francis K Buadi, Sikander Ailawadhi, et al.
Mayo Clinic Proceedings
|
June 5, 2021
Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update
Eli Muchtar, Angela Dispenzieri, Morie A Gertz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 8, 2025
Genomics Define Malignant Transformation in Myeloma Precursor Conditions
Francesco Maura, P Leif Bergsagel, Bachisio Ziccheddu, et al.
American Journal of Hematology
|
December 10, 2019
Impact of MYD88<sup>L265P</sup> mutation status on histological transformation of Waldenström Macroglobulinemia
Saurabh Zanwar, Jithma P Abeykoon, Eric Durot, et al.
Mayo Clinic Proceedings
|
August 13, 2010
Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines
Stephen M Ansell, Robert A Kyle, Craig B Reeder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2025
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
Hervé Avet-Loiseau, Faith E Davies, Mehmet K Samur, et al.
Blood Advances
|
April 22, 2026
A multi-center study of progression-risk and outcomes in solitary bone plasmacytoma with and without marrow involvement
Kenneth Jc Lim, Maximilian Johannes Steinhardt, Matthew J Rees, et al.
JAMA Oncology
|
January 6, 2017
Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016
Prashant Kapoor, Stephen M Ansell, Rafael Fonseca, et al.
Nature
|
March 25, 2011
Initial genome sequencing and analysis of multiple myeloma
Michael A Chapman, Michael S Lawrence, Jonathan J Keats, et al.
Page
of 57
Search research articles
Search
Showing results (551-560 of 566) with videos related to
Sort By:
Page
of 57
The Lancet. Oncology
|
August 12, 2016
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar, Bruno Paiva, Kenneth C Anderson, et al.
Bone Marrow Transplantation
|
July 11, 2018
Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement
Wilson I Gonsalves, Francis K Buadi, Sikander Ailawadhi, et al.
Mayo Clinic Proceedings
|
June 5, 2021
Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update
Eli Muchtar, Angela Dispenzieri, Morie A Gertz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 8, 2025
Genomics Define Malignant Transformation in Myeloma Precursor Conditions
Francesco Maura, P Leif Bergsagel, Bachisio Ziccheddu, et al.
American Journal of Hematology
|
December 10, 2019
Impact of MYD88<sup>L265P</sup> mutation status on histological transformation of Waldenström Macroglobulinemia
Saurabh Zanwar, Jithma P Abeykoon, Eric Durot, et al.
Mayo Clinic Proceedings
|
August 13, 2010
Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines
Stephen M Ansell, Robert A Kyle, Craig B Reeder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2025
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
Hervé Avet-Loiseau, Faith E Davies, Mehmet K Samur, et al.
Blood Advances
|
April 22, 2026
A multi-center study of progression-risk and outcomes in solitary bone plasmacytoma with and without marrow involvement
Kenneth Jc Lim, Maximilian Johannes Steinhardt, Matthew J Rees, et al.
JAMA Oncology
|
January 6, 2017
Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016
Prashant Kapoor, Stephen M Ansell, Rafael Fonseca, et al.
Nature
|
March 25, 2011
Initial genome sequencing and analysis of multiple myeloma
Michael A Chapman, Michael S Lawrence, Jonathan J Keats, et al.
Page
of 57